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Abstract Proton magnetic resonance spectroscopy
(1H-MRS) has been used in a number of studies to assess
noninvasively the temporal changes of lactate (Lac) in the
activated human brain. Migraine neurobiology involves
lack of cortical habituation to repetitive stimuli and a
mitochondrial component has been put forward. Our group
has recently demonstrated a reduction in the high-energy
phosphates adenosine triphosphate (ATP) and phospho-
creatine (PCr) in the occipital lobe of migraine without
aura (MwoA) patients, at least in a subgroup, in a phos-
phorus MRS (31P-MRS) study. In previous studies, basal
Lac levels or photic stimulation (PS)-induced Lac levels
were found to be increased in patients with migraine with
aura (MwA) and migraine patients with visual symptoms
and paraesthesia, paresia and/or dysphasia, respectively.
The aim of this study was to perform functional 1H-MRS at
3 T in 20 MwoA patients and 20 control subjects. Repet-
itive visual stimulation was applied using MR-compatible
goggles with 8 Hz checkerboard stimulation during
12 min. We did not observe any significant differences in
signal integrals, ratios and absolute metabolite concentra-
tions, including Lac, between MwoA patients and controls
before PS. Lac also did not increase significantly during
and following PS, both for MwoA patients and controls.
Subtle Lac changes, smaller than the sensitivity threshold
(i.e. estimated at 0.1–0.2 lmol/g at 3 T), cannot be
detected by MRS. Our study does, however, argue against a
significant switch to non-aerobic glucose metabolism dur-
ing long-lasting PS of the visual cortex in MwoA patients.
Keywords Migraine without aura  Functional 1H-MRS 
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Introduction
Migraine is a common, disabling, primary headache dis-
order, with episodic manifestations that affects women
three times more than men [1]. Migraine is divided into
two major subtypes: migraine without aura (MwoA) and
migraine with aura (MwA) [2].
The pathophysiology is still largely unknown despite a
surge of interest because of the high prevalence and socio-
economic impact [1]. Subcortical structures, probably
including brainstem, hypothalamus and thalamus, are
involved in the generation of migraine attacks [3]. Even
more puzzling are the mechanisms at the basis of the
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interictal brain disorder that predisposes migraine patients
to develop an attack. Factors such as genetic background
[4–6], nitric oxide hypersensitivity [7], lack of cortical
habituation [8, 9], and a disturbed energy metabolism [10]
may determine the migraine threshold.
In the last 20 years, several magnetic resonance spec-
troscopy (MRS) studies have been performed in migraine
patients. MRS is a technique to obtain in vivo biochemical
information noninvasively. Many of these studies comprised
phosphorus MRS (31P-MRS) and suggested an interictal
energy disturbance in the brain of migraine patients ([10] and
references herein). Other studies employed proton MRS
(1H-MRS) and yielded a lot of heterogeneous, sometimes
contradictory, results for metabolites including N-acetylas-
partate (NAA: a neuronal marker), total creatine (tCr: a
marker of energy metabolism), choline (Cho: a marker for
membrane turnover) and myo-inositol (a glial marker) ([11]
and references herein). An interesting finding was the ele-
vated interictal level of lactate (Lac) in the occipital visual
cortex of a heterogeneous group of migraine patients
(i.e., MwA, basilar-type migraine, migrainous infarction)
[12], suggesting a deranged oxidative glycolysis. A similar
observation was made in four patients with familial hemi-
plegic migraine (FHM), a rare subtype of MwA [13]. In a
functional 1H-MRS study, photic stimulation (PS) resulted in
a Lac increase in the visual cortex of migraine patients with
migraine with visual symptoms and paraesthesia, paresia
and/or dysphasia, but not in MwA patients, in which Lac was
already higher than normal in the resting state [14].
Lac is an interesting metabolite due to its role as an
intermediate of glucose metabolism and as a marker of
metabolic activity under either aerobic and anaerobic
conditions (Fig. 1) [15].
Therefore, the function of Lac during brain activation
has been at the centre of brain energy metabolism research
[16]. Fox et al. [17] found a mismatch between DCMRO2
(variation of cerebral metabolic rate of oxygen), which
increased by 5%, and DCMRgl (variation of cerebral met-
abolic rate of glucose) and DCBF (variation of cerebral
blood flow), which both increased by 30–50% during
prolonged neuronal activity in a positron emission
tomography (PET) study. Pellerin and Magistretti [18]
hypothesized that Lac, and not glucose, was the main
metabolic substrate for activated neurons, as part of the so-
called astrocyte-neuron Lac shuttle (ANLS). Several 1H-
MRS studies reported an increase in Lac during prolonged
PS [19–21]. However, a decrease in Lac was also observed
following the presentation of an impulsive PS, partly
refuting the ANLS theory [22].
Our group demonstrated a decreased level of high-
energy phosphates in the occipital visual cortex of a sub-
group of MwoA patients as compared to controls with
31P-MRS [10]. It was hypothesized that the observed
adenosine triphosphate (ATP) is attributed to a reduced
aerobic glycolysis and oxidative phosphorylation. This
reduction in high-energy phosphates added further evi-
dence to the hypothesis of the presence of a mitochondrial
component in the pathophysiology of migraine. The
question remained whether there would be an associated
switch to anaerobic glycolysis, illustrated by an increase in
Lac concentration. A resting state 1H-MRS study, however,
did not show any quantifiable Lac in the visual cortex of
the same MwoA patient group as in the 31P-MRS study
[11]. The aim of this study was to investigate potential Lac
changes with 1H-MRS in the occipital visual cortex of




20 MwoA patients (31:9  9:1 years; 3 men) and 20 age- and
gender-matched control subjects (31:9  10:3 years; 3 men)
were studied with functional 1H-MRS. All patients were
recruited by the local Headache Clinic of the Ghent Uni-
versity Hospital where they were diagnosed with MwoA
according to the criteria of the International Headache
Fig. 1 Simplified scheme of cerebral glucose metabolism. In aerobic
circumstances glucose is converted into pyruvate and enters the
tricarboxylic acid (TCA) cycle/oxidative phosphorylation, resulting in
ATP production. Through the creatine kinase (CK) reaction, adeno-
sine diphosphate (ADP) can be rephosphorylated, with conversion
from phosphocreatine (PCr) to Cr. When aerobic energy metabolism
is insufficient, there can be a switch to anaerobic glycolysis, resulting
in an accumulation of Lac, enzymatically converted by Lac
dehydrogenase (LDH)
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Society [2]. On average, patients experienced 3.6 ± 1.1
attacks per month, were not using any prophylactic medi-
cation and were attack-free for at least 48 h before the fMRS
study. A possible attack after the study was verified by
e-mail. The protocol was approved by the local ethics com-
mittee and all subjects gave written informed consent.
1H-MRS and photic stimulation
Measurements were performed on a 3 T Siemens Trio Tim
whole-body scanner (Erlangen, Germany), using a 26.5-
cm-diameter quadrature transmit/receive dual tuned
(31P 1 H) birdcage head coil (Rapid Biomedical, Wu¨rz-
burg-Rimpar, Germany). Spectra were acquired using a
single voxel point-resolved spin echo sequence (PRESS),
with chemical-shift-selective (CHESS) water suppression.
Automatic shimming with manual fine tuning of the B0
magnetic field was used as well as iterative semi-automatic
optimization of the transmitter voltage.
The volume of interest (VOI) was placed in the primary
visual cortex (Brodmann area 17), centered on the calcarine
fissure (Fig. 2a), localized on T1-weighted gradient-echo
images in three orthogonal planes with a slice thickness of
1 mm, a repetition time (TR) of 1550 ms and an echo time
(TE) of 2.37 ms. VOI size was 20  20  20 mm3: For each
subject, 64 water-suppressed spectra (TE = 288 ms,
TR = 2,000 ms, 8 averages), as well as 10 water-unsup-
pressed spectra at different TE (30, 50, 70, 90, 110, 150,
200, 300, 500, 1,000 ms) and a TR of 10,000 ms (1 average)
were acquired. The raw data of each acquisition consisted of
1,024 complex-valued data points, at a sampling period of
0.833 ms. The corresponding bandwidth was 1200 Hz. The
total duration of the examination was approximately 40 min.
PS was obtained by the projection of a black-and-white
checkerboard, reversing at 8 Hz, and was viewed through MR-
compatible goggles. Subjects were instructed to fixate a cross
hair in the centre of the reversing checkerboard. The control
condition consisted of the projection of a black screen. The
Fig. 2 a Sagittal T1-weighted image with a 20-mm cubic VOI
localized in the occipital visual cortex. b MR spectrum of a phantom
containing NAA (2.01 ppm) and Lac (1.31 ppm). c Stack plot of
spectra obtained before (B), during (stimulation 1, S1 and stimulation
2, S2) and following PS (after, A) in controls. d Stack plot of spectra
obtained before (B), during (S1 and S2) and following PS (A) in
MwoA patients. In vivo metabolites Lac (1.31 ppm), NAA
(2.01 ppm), tCr (3.03 ppm) and Cho (3.19 ppm) are marked in the
spectra
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experimental time course was: 602400 baseline phase (black
screen) corresponding to 16 spectra; 1204800 on phase (revers-
ing checkerboard) corresponding to 32 spectra; and again 602400
baseline phase (black screen) corresponding to 16 spectra.
A phantom was used to evaluate the 1H-MRS protocol
and contained an aqueous solution of 10 mM NAA and
1 mM Lac (Sigma Aldrich). Sodium azide (NaN3) was
added as an antimycotic agent. The phantom was made of
plastic, was spherical and had a diameter of 10.4 cm. A
spectrum obtained in the phantom is shown in Fig. 2b.
Spectral analysis
Both water-suppressed and water-unsuppressed spectra
were recorded in this study.
Water-unsuppressed spectra were processed without
apodization and fitted by a single component using Hankel
Lanczos Squares Singular Values Decomposition (HLSVD),
a method based on the Lanczos algorithm and included in the
jMRUI package [24], yielding an estimation of the water
signal integral.
In the water-suppressed spectra, the residual water reso-
nance was removed by HLSVD [25]. The signals of Lac,
NAA, tCr and Cho were referenced at 1.31, 2.01, 3.03 and
3.19 ppm, respectively (Fig. 2c, d). The spectra were sum-
med and averaged over 16 spectra, according to the corre-
sponding condition. Following apodization (Lorentzian,
5 Hz) and phase correction, the water-suppressed spectra
were fitted by the time-domain semi-parametric algorithm
QUEST [26], software which is also included in the jMRUI
package. QUEST is a non-linear least-squares algorithm that
fits a time-domain model function, made up from a basis set
of quantum-mechanically simulated whole-metabolite sig-
nals. These whole-metabolite signals were simulated with
the software package NMR-SCOPE [27], which uses
advanced prior knowledge and computes theoretical
metabolite signals in terms of spin Hamiltonian parameters
[28]. The PRESS sequence was simulated with NMR-
SCOPE. Signal basis sets of NAA, tCr, Cho and Lac were
created for a TE of 288 ms, so that the J-coupling modula-
tions were the same as in vivo. We fitted all metabolites to
reduce the effect of the spectral overlap. Each simulated
metabolite spectrum was composed of multiple peaks from
both the coupled and uncoupled protons.
Quantification
Metabolite ratios of NAA/tCr, Cho/tCr, Lac/tCr and Lac/
NAA were calculated using the signal integrals derived
with QUEST.
Absolute in vivo concentrations, using the phantom
replacement technique with NAA as a reference, were also
calculated, using the following equation [29]:
½Ci ¼ ½CrSiVrNrcT1r cT2r Tiqicload
SrViNicT1i cT2i Trqrccsf
ð1Þ
Subscripts i and r correspond with in vivo and the reference
phantom, respectively, [C] is the metabolite concentration,
the NAA metabolite concentration [Cr] in the reference
phantom was 10 mM, S is the signal integral (derived with
QUEST), V is the volume of the voxel from which the
signal is acquired, N is the number of protons that con-
tribute to the spectral line (N = 3 for NAA, tCr and Lac,
N = 9 for Cho), cT1 and cT2 are correction factors for the
signal loss caused by longitudinal (T1) and transversal (T2)
relaxation time, respectively, T is the absolute temperature
(Ti ¼ 310:16 K in the volunteer and Tr ¼ 294:16 K in the
reference phantom), q is the density of water, cload is a
correction factor that accounts for different coil loading
and ccsf is the correction factor for partial volume effects,
i.e. the fraction of cerebrospinal fluid (CSF) compared to
the fraction of water in the brain parenchyma in the VOI.
The volume ratio Vr=Vi cancels from the equation since V
was the same in the reference phantom and in vivo, i.e.
20  20  20 mm3: For the calculation of the different
correction factors, we refer to a recent publication on
quantitative 1H-MRS in MwoA [11]. T1 and T2 relaxation
times of Lac were derived from another study [30].
Statistical analysis
Statistical analysis was performed using the SPSS software
(SPSS 15.0 for Windows; Chicago, IL). Descriptive sta-
tistics were calculated for age, gender, signal-to-noise ratio
(SNR), signal integral variations, metabolite ratios and
absolute metabolite concentrations. To determine whether
detectable changes in metabolite ratios and absolute
metabolite concentrations occur in MwoA patients as
compared to controls, before, during and after PS, a repe-
ated measures ANOVA was performed. The metabolite
ratios and concentrations were tested against the hypothesis
of within-subject variations (i.e., condition) and between-
subject variations (i.e., group). A least significant differ-
ence (LSD) test and a Scheffe´ test were used to evaluate
possible group differences. Equality of variances was ver-
ified with the Levene’s test and normal distribution of data
was evaluated by a Kolmogorov–Smirnov test. Results
were considered to be significant for P \ 0.05.
Results
Spectra obtained during rest and stimulation conditions
from both control subjects and MwoA patients are shown
in Fig. 2c, d, respectively. Shimming resulted in linewidths
around 8 Hz for water.
298 J Headache Pain (2011) 12:295–302
123
With the achieved SNR of the summed spectra at a TE
of 288 ms, no other peaks than NAA, tCr, Cho and Lac
were evident. On average the SNR was identical in the
control and MwoA patient group (Table 1). SNR varied
around 5% between the resting and stimulation phases
(DSNR).
In a phantom, signal integrals varied from \0.5% for
NAA to 1–2% for Lac during the time course of the func-
tional paradigm. Table 2 illustrates the total average in vivo
signal integral variation per metabolite, as well as the
average variation between the different conditions of the
stimulation paradigm. The NAA signal integral has a
coefficient of variation (CV) of approximately 3% during
the course of the paradigm. For the tCr and the Cho signal,
CV has somewhat higher values: around 7 and 11%,
respectively. The highest CV, as expected, is found for the
small Lac signal integral at around 30%. There are no dif-
ferences between MwoA patients and control subjects for
these abovementioned values (P [ 0.05). When analyzing
the signal integral variation between the three conditions,
we observed considerable (for NAA and tCr) to very large
(for Cho and Lac) standard deviations.
The evolution of metabolite ratios and absolute con-
centrations during the stimulation paradigm are shown in
Tables 3, 4, respectively. No significant differences in
metabolite ratios, including Lac/tCr and Lac/NAA, and
absolute metabolite concentrations, including [Lac], were
observed between the different conditions in both the
MwoA patient and the control group (P [ 0.05). Also no
significant differences were found between MwoA patients
and controls, when looking at separate stimulation condi-
tions (P [ 0.05).
Discussion
There were several good reasons to perform functional 1H-
MRS in the visual cortex of MwoA patients.
The visual cortex is both easily stimulated and an
interesting brain region because of its higher energy
metabolism. The occipital lobe was found to have a sig-
nificantly higher regional CMRO2 as compared to other
cortical regions [31], and, according to a PET study, the
regional CMRgl was found to be the highest in occipital
Table 1 SNR
Controls MwoA patients
SNR 2.4 ± 0.37 2.4 ± 0.35
DSNR (%) 5.2 ± 2.3 5.5 ± 2.5
Table 2 Signal integral variation (%)
Totala Stimulation - Beforeb After - Stimulationc After - Befored
Controls MwoA patients Controls MwoA patients Controls MwoA patients Controls MwoA patients
NAA 2.9 ± 1.7 3.0 ± 1.1 1.7 ± 3.3 1.3 ± 5.2 -2.5 ± 4.4 -1.4 ± 3.5 -0.8 ± 4.7 -0.3 ± 4.4
tCr 7.3 ± 4.4 7.7 ± 4.1 4.9 ± 14.4 4.5 ± 11.2 -4.9 ± 10.6 -0.5 ± 9.8 -1.4 ± 8.4 3.8 ± 14.1
Cho 11.9 ± 7.9 11.7 ± 7.1 8.1 ± 29.5 -0.3 ± 18.5 -2.4 ± 16.7 1.9 ± 19.5 3.1 ± 22.5 1.8 ± 28.7
Lac 33.4 ± 18.4 29.9 ± 17.2 16.9 ± 53.1 31.4 ± 74.5 7.9 ± 86.4 -5.8 ± 45.5 8.3 ± 55.9 -0.7 ± 42.8
a Total reflects the average signal integral variation of all conditions combined (before, during and after PS)
b Signal integral variation of the signals obtained before and during PS
c Signal integral variation of the signals obtained during and following PS
d Signal integral variation of the signals obtained before and following PS
Table 3 Ratios
Beforea Stimulation1 Stimulation2 After
NAA/tCr Controls 2.34 ± 0.269 2.38 ± 0.289 2.26 ± 0.244 2.40 ± 0.239
MwoA patients 2.46 ± 0.248 2.41 ± 0.233 2.42 ± 0.233 2.38 ± 0.256
Cho/tCr Controls 0.221 ± 0.061 0.236 ± 0.059 0.214 ± 0.050 0.224 ± 0.036
MwoA patients 0.222 ± 0.059 0.228 ± 0.047 0.221 ± 0.046 0.223 ± 0.045
Lac/tCr Controls 0.242 ± 0.108 0.247 ± 0.118 0.270 ± 0.118 0.243 ± 0.117
MwoA patients 0.267 ± 0.146 0.249 ± 0.099 0.288 ± 0.127 0.258 ± 0.122
Lac/NAA Controls 0.103 ± 0.044 0.104 ± 0.048 0.120 ± 0.053 0.104 ± 0.054
MwoA patients 0.112 ± 0.060 0.105 ± 0.043 0.126 ± 0.046 0.110 ± 0.050
a All conditions were averaged over 16 spectra
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white matter and the visual cortex [32]. Migraine has been
the subject of a large cohort of MRS studies (see reviews in
[10, 11]). More specifically, Lac was found to be increased
in the visual cortex at rest or following PS of MwA patients
and migraine patients with a more complex phentotype
(i.e., visual symptoms and one of the following symptoms:
paraesthesia, paresia or dysphasia), respectively [12, 13,
14, 33]. A resting state 31P-MRS study in MwoA patients,
performed by our group, demonstrated a decrease in high-
energy phosphates (ATP and PCr) in the visual cortex,
implying a reduction in aerobic metabolism [10]. Further-
more, no quantifiable Lac was observed in the same MwoA
patient group, implying there is no significant switch to
anaerobic glycolysis in the resting state [11]. The aim of
this study was to elucidate whether Lac would increase in
MwoA during and following PS.
In the present functional 1H-MRS study we did not
observe any significant differences in signal integrals,
ratios and absolute metabolite concentrations (including
for Lac) between MwoA patients and controls, before PS.
These findings are in contrast to observations in three
studies covering MwA (including FHM and basilar-type
migraine), which reported elevated basal Lac levels [12–
14]. The authors of the abovementioned studies suggested
that the accumulation of Lac was a marker for a distur-
bance in oxidative glycolysis, related to energy metabolism
impairment, which is typical for mitochondrial diseases
[34].
We also did not observe a significant increase of Lac
during and following PS, both for MwoA patients and
controls. In another comparative fMRS study between
patients with MwA and migraine patients with both visual
symptoms and paraesthesia, paresia and/or dysphasia (but
not MwoA), a PS-induced Lac/NAA increase was reported
only in the migraine patients with the more complex phe-
notype (i.e., visual and other symptoms) while no changes
were observed in the MwA and control group [14]. It was
postulated that the lack of stimulation-induced Lac increase
in MwA and also in patients with mitochondriopathies
might be partially attributed to a saturation of Lac trans-
porter systems [35]. In the subgroup of MwA, with high
resting-state [Lac] levels, it was hypothesized that the aura
was limited to the visual cortex, whereas in the subgroup of
migraine patients with both visual symptoms and paraes-
thesia, paresia and/or dysphasia, this was not the case.
Experiments demonstrated that decreased pH, which would
accompany increased extracellular Lac, is an inhibiting
factor for cortical spreading depression, which is believed
to be associated with the aura symptoms [36].
The lack of a significant increase in Lac in the healthy
control population post-PS in our study is in contrast to
some other early fMRS studies [19–21], in which PS-
induced Lac increases of 60–150% were observed.
However, several methodological issues have been raised
concerning Lac visibility in MRS as well as Lac dynamics
following PS, which are related to low Lac concentrations
under different experimental conditions [37, 38]. This led
to the need for optimization of the sensitivity and accuracy
of fMRS methodology. Mangia et al. [39–41] reported
about these issues in several advanced 1H-MRS studies and
observed an increase in [Lac] of 0:10:2 lmol/g in the first
minute of PS, corresponding to an increase of only 20%. In
contrast to most previous reports [19, 20, 21, 37, 38], these
studies were performed at ultrahigh field strength (i.e.,
7 T), resulting in larger chemical shift dispersions and
higher SNR compared to lower field strenghts. Further-
more, in these studies data were acquired with ultrashort
TE and a long TR, minimizing T2 and T1 relaxation effects,
and, ultimately leading to very reproducible results with a
high SNR. We acquired data using a long TE (i.e., 288 ms)
as in several previous fMRS studies [20, 37, 38], resulting
in low SNR spectra, large variability in Lac signal ampli-
tudes, and consequently high standard deviations. Lac
changes could not be identified at 3 T in the present study
in both controls and MwoA patients, as the variations are
lower than the sensitivity threshold of 0:1 lmol/g (maxi-
mum 0.09 mM, see Table 4), determined in a functional
1H-MRS study in healthy volunteers at 7 T [39]. It should
Table 4 Absolute concentrations (mM)
Beforea Stimulation1 Stimulation2 After
½NAA Controls 14.92 ± 1.39 15.05 ± 1.39 14.75 ± 1.53 14.84 ± 1.70
MwoA patients 15.22 ± 1.76 15.36 ± 1.88 15.30 ± 1.90 15.21 ± 1.80
½tCr Controls 12.68 ± 1.60 12.63 ± 1.69 13.14 ± 1.47 12.25 ± 1.47
MwoA patients 12.43 ± 1.84 12.59 ± 1.84 12.54 ± 1.69 12.67 ± 1.59
½Cho Controls 0.88 ± 0.22 0.93 ± 0.17 0.89 ± 0.21 0.88 ± 0.18
MwoA patients 0.92 ± 0.22 0.88 ± 0.18 0.89 ± 0.17 0.90 ± 0.18
½Lac Controls 0.51 ± 0.19 0.53 ± 0.23 0.60 ± 0.24 0.52 ± 0.24
MwoA patients 0.55 ± 0.29 0.60 ± 0.24 0.62 ± 0.23 0.53 ± 0.26
a All conditions were averaged over 16 spectra
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also be emphasized that the calculated absolute metabolite
concentrations (i.e., around 0.5–0.6 mM) are in the range
of what is assumed as normal for healthy brain (i.e., 0.2–
1.0 mM); and Lac increases of up to 0.2 mM are unlikely
to reflect a switch to anaerobic glycolysis, according to
Mangia et al. [40].
In conclusion, we can state that in this study no oberv-
able changes in Lac were found in MwoA patients, both at
rest and following PS. This is in contrast to observations in
MwA patients (and variants) as reported by others. This
suggests that the observed Lac increase in previous MRS
studies at 1.5 T in MwA is linked to aura, and therefore
absent in our cohort of MwoA patients. It has to be men-
tioned that subtle metabolic changes (such as a small rise in
Lac, smaller than 0:1 lmol/g) may not have been detected
in healthy volunteers and MwoA patients, due to the used
experimental conditions (3 T, sequence, long TE,. . .).
However, we performed a robust quantitative analysis in
both a homogeneous MwoA patient group, and an age- and
gender-matched control group. Our study argues against a
significant switch to non-aerobic glucose metabolism dur-
ing long-lasting PS of the visual cortex of MwoA patients.
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